Rammensee HG - Search Results

1

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.

Singh-Jasuja H, Emmerich NP, Rammensee HG. Singh-Jasuja H, et al. Among authors: rammensee hg. Cancer Immunol Immunother. 2004 Mar;53(3):187-95. doi: 10.1007/s00262-003-0480-x. Epub 2004 Jan 31. Cancer Immunol Immunother. 2004. PMID: 14758508 Free PMC article. Review.

2

Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.

Wallny HJ, Deres K, Faath S, Jung G, Van Pel A, Boon T, Rammensee HG. Wallny HJ, et al. Among authors: rammensee hg. Int Immunol. 1992 Oct;4(10):1085-90. doi: 10.1093/intimm/4.10.1085. Int Immunol. 1992. PMID: 1283332

3

Isolation of human minor histocompatibility peptides.

Sekimata M, Griem P, Egawa K, Rammensee HG, Takiguchi M. Sekimata M, et al. Among authors: rammensee hg. Int Immunol. 1992 Feb;4(2):301-4. doi: 10.1093/intimm/4.2.301. Int Immunol. 1992. PMID: 1622900

4

Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.

Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R. Vogt AB, et al. Among authors: rammensee hg. J Immunol. 1994 Aug 15;153(4):1665-73. J Immunol. 1994. PMID: 7519208

5

Analysis of a naturally occurring HLA class I-restricted viral epitope.

Falk K, Rötzschke O, Stevanović S, Gnau V, Sparbier K, Jung G, Rammensee HG, Walden P. Falk K, et al. Among authors: rammensee hg. Immunology. 1994 Jul;82(3):337-42. Immunology. 1994. PMID: 7525458 Free PMC article.

6

Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.

Arnold D, Wahl C, Faath S, Rammensee HG, Schild H. Arnold D, et al. Among authors: rammensee hg. J Exp Med. 1997 Aug 4;186(3):461-6. doi: 10.1084/jem.186.3.461. J Exp Med. 1997. PMID: 9236199 Free PMC article.

7

Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.

Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W. Brossart P, et al. Among authors: rammensee hg. Cancer Res. 1998 Feb 15;58(4):732-6. Cancer Res. 1998. PMID: 9485028

8

Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells.

Böhm CM, Hanski ML, Stefanović S, Rammensee HG, Stein H, Taylor-Papadimitriou J, Riecken EO, Hanski C. Böhm CM, et al. Among authors: rammensee hg. Int J Cancer. 1998 Mar 2;75(5):688-93. doi: 10.1002/(sici)1097-0215(19980302)75:5<688::aid-ijc5>3.0.co;2-v. Int J Cancer. 1998. PMID: 9495235 Free article.

9

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.

Malcherek G, Wirblich C, Willcox N, Rammensee HG, Trowsdale J, Melms A. Malcherek G, et al. Among authors: rammensee hg. Eur J Immunol. 1998 May;28(5):1524-33. doi: 10.1002/(SICI)1521-4141(199805)28:05<1524::AID-IMMU1524>3.0.CO;2-T. Eur J Immunol. 1998. PMID: 9603457 Free article.

10

Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire.

Obst R, Münz C, Stevanović S, Rammensee HG. Obst R, et al. Among authors: rammensee hg. Eur J Immunol. 1998 Aug;28(8):2432-43. doi: 10.1002/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0. Eur J Immunol. 1998. PMID: 9710221 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page